Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey (EDUCOVID)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04732858 |
|
Recruitment Status :
Active, not recruiting
First Posted : February 1, 2021
Last Update Posted : February 9, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| COVID-19 | Other: Cross sectional e-Survey on surgeons exposed to any educational intervention |
| Study Type : | Observational |
| Estimated Enrollment : | 50 participants |
| Observational Model: | Ecologic or Community |
| Time Perspective: | Cross-Sectional |
| Official Title: | Educational Interventions to Integrate Surgical Staff Within Medical Units During the COVID-19 Pandemic: EDUCOVID Cross-sectional, E-survey |
| Actual Study Start Date : | March 1, 2020 |
| Actual Primary Completion Date : | August 31, 2020 |
| Estimated Study Completion Date : | June 1, 2021 |
- Other: Cross sectional e-Survey on surgeons exposed to any educational intervention
Educational intervention was considered as any procedure or program to facilitate the acquisition of basic skills about the disease, its ramifications and treatment2,6,7:
-
Education in infectious disease, including
- "pandemic" training for health personnel
- Personal protective equipment (PPE) and protection.
- Specific speed-training focusing on environmental control (decontamination area, dressing...), personal protection, hand hygiene, sample management, risky gestures, control measures.
-
Intensive care education:
- mechanical ventilation
- airways management
- emergencies and cardiovascular drugs
- Intensive care monitoring systems
- Basic nurse skills
- COVID-specific clinical management
-
- Kirkpatrick level 3 on a 5-modalities Likert scale [ Time Frame: once at the time of survey ]The primary endpoint of the e-survey was to explore the effectiveness of educational interventions experienced by responders, considered as a whole "bundle" (and not one-by-one), among the surgeons exposed to a training program, on behavior change (Kirkpatrick level 3) in their daily role during their re-affectation within a medical COVID-unit. Behavior change represents a change in the daily role of healthcare professionals (for example, referral of patients with suspected COVID to the most appropriate screening and care pathway). For this survey, we considered subjective measures (self-assessment on a Likert scale on 5 modalities) of behavior change.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- residents, fellows, consultants and physicians of any grade and affiliated to any surgical specialty
Exclusion Criteria:
- Mecical speciality
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04732858
| France | |
| Assistance Publique Hôpitaux de Paris - GHU AP-HP Hôpitaux Universitaires Henri-Mondor | |
| Créteil, France, 94010 | |
| Principal Investigator: | Raffaele BRUSTIA, MD,PhD | Assistance Publique - Hôpitaux de Paris |
| Responsible Party: | Assistance Publique - Hôpitaux de Paris |
| ClinicalTrials.gov Identifier: | NCT04732858 |
| Other Study ID Numbers: |
APHP201297 |
| First Posted: | February 1, 2021 Key Record Dates |
| Last Update Posted: | February 9, 2021 |
| Last Verified: | November 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
2019-nCoV COVID-19 Pandemic Educational intervention Medical education |
|
COVID-19 Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia Virus Diseases |
Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases |

